In Silico Proof of the Effect of Quercetin and Umbelliferone as Alpha-Amylase Inhibitors, Which Can Be Used in the Treatment of Diabetes
Öz
Aim of study: The aim of this study is to show the in silico evidences about the potential use of quercetin and umbelliferone as α-amylase inhibitors, which is important for the treatment of diabetes.
Material and methods: The possible conformations and orientations of quercetin, umbelliferone, and acarbose, in binding to the active sites of alpha-amylase, were analysed by CASTp server. The molecular dockings of these compounds to the potential active site were performed by AutoDock Tools to obtain 3D interactions and binding energies. In addition, the interaction scores were calculated by iGEMDOCK. The 2D enzyme-inhibitor interactions, which clearly show the interactions at the active sites, were analysed by LigPlot+. The drug-likeness properties of quercetin and umbelliferone were compared to acarbose by DruLiTo software and SWISSADME server. The absorption, distribution, metabolism, excretion, and toxicity (ADMET) scores, which present the pharmacokinetic properties of the compounds were analysed by ADMETLab, admetSAR, and PreADMET servers
Main results: As a result, the α-amylase inhibitor activity and the potential use of quercetin and umbelliferone were proved in silico.
Highlights: The results of the study clearly put forward that quercetin and umbelliferone could have possible medicinal use in the treatment of diabetes
Anahtar Kelimeler
Quercetin, Umbelliferone, Acarbose, Alpha-Amylase, Inhibitor, Molecular Docking, ADMET
Kaynakça
- Balavignesh, V., Srinivasan, E., Ramesh Babu, N. G. & Saravanan, N. (2013). Molecular docking study ON NS5B polymerase of hepatitis c virus by screening of volatile compounds from Acacia concinna and ADMET prediction. International Journal of Pharmaceutical and Life Sciences, 4(4), 2548-2558.
- Biovia, Dassault Systèmes. (2019). Discovery Studio Visualizer v.20.1.0.19295 [Computer software]. San Diego: Dassault Systèmes.
- Brandsch, M., Ganapathy, V. & Leibach, F.H. (1995). H (+)-peptide cotransport in Madin-Darby canine kidney cells: expression and calmodulin-dependent regulation. American Journal of Physiology-Renal Physiology, 268(3), F391-F397.
- Castillo-Garit, J., Cañizares-Carmenate, Y., Marrero-Ponce, Y., Abad, C. & Torrens, F. (2014). Prediction of ADME properties, Part 1: Classification models to predict Caco-2 cell permeability using atom-based bilinear indices. Afinidad, 71(566), 124-138.
- Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W. & Tang, Y. (2012). admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099-3105.
- Daina, A., Michielin, O. & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 1-13.
- Dong, J., Wang, N.N., Yao, Z.J., Zhang, L., Cheng, Y., Ouyang, D., Lu, A.P. & Cao, D.S. (2018). ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. Journal of Cheminformatics, 10(1), 1-11.
- Drug Likeness Tool. (2018). http://www.niper.gov.in/pi_dev_tools/DruLiToWeb/DruLiTo_index.html
- Egan, W.J., Merz, K.M. & Baldwin, J.J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43(21), 3867-3877.
- Elmeliegy, M., Vourvahis, M., Guo, C. & Wang, D. D. (2020). Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: Review of clinical drug–drug interaction studies. Clinical pharmacokinetics, 59(6), 699-714.